West Pharmaceutical Services (WST) Revenue — Quarter Ended Mar 31, 2024
Revenue declined in the current quarter, moving lower than both the immediately preceding period and the same quarter a year earlier. The decrease continues a downward trajectory observed over recent quarters.
Key takeaway
Quarter ended Mar 31, 2024 · FY2024 Q1
Revenue declined in the current quarter, moving lower than both the immediately preceding period and the same quarter a year earlier. The decrease continues a downward trajectory observed over recent quarters.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$695.4M
Revenue reported for this quarter.
Quarter-over-quarter
-5.0%
Change from the immediately preceding quarter.
Year-over-year
-3.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$2.9B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2023 | $753.8M | -2.3% |
| Sep 30, 2023 | $747.4M | +8.8% |
| Dec 31, 2023 | $732M | +3.3% |
| Mar 31, 2024 | $695.4M | -3.0% |
Revenue performance
Reported revenue for the quarter fell compared to the prior quarter and was also lower than the same quarter one year ago.
Quarterly comparison
Compared with the preceding quarter, revenue declined. Versus the same quarter in the prior year, revenue also decreased.
What to watch
The company noted a decline in net cash provided by operating activities during the current quarter compared to the same period last year, primarily due to lower operating results.